Data as of Jul 25, 2026 · Based on 2,718,867 AI responses across 9,511 prompts · See how Parse measures this
PhaseV Trial Optimizer uses AI/ML to simulate millions of adaptive, Bayesian, and fixed trial designs, reducing sample sizes by 10–40% while preserving statistical power. It enables real-time evaluation of trial parameters and causal ML-driven insights from prior data to cut costs and duration across Phase 1–3 studies.
Parse Score